Notes to the Financial Statements
Notes to the Financial Statements
continued
12 Intangible assets - continued
continued
13 Property, plant and equipment
• Goodwill of €23,572,000 arising on the purchase of a controlling interest in the Group’s shareholding in Lindchem DAC (note 35).
• Goodwill of €1,350,000 arising on the acquisition of the ostomy trade and related assets of Murray’s Medical Equipment
Limited (note 35).
The disposals reflect goodwill with a net book value of €2,756,000 (cost: €4,840,000 less impairment €2,084,000) associated with the
disposal of the Group’s interest in three pharmacies (note 8).
The Uniphar Group was a registered trademark known as Life Pharmacy. This trademark is used by customers of Uniphar to operate
under the common symbol of Life Pharmacy. Uniphar in partnership with pharmacy customers are developing a symbol group and the
trademark symbol will be a central part of developing the Life brand. Amortisation of the trademark will commence upon the finalisation
of brand development in 2017.
The Group continued to review the carrying value of goodwill associated with subsidiary companies previously acquired as at 31
December 2016. Based upon the trading performance in 2016 and outlook, the Group recognised an impairment to goodwill of
€19,947,000 (2015: €1,402,000) in relation to retail pharmacies. Of the total goodw